ClinicalTrials.Veeva

Menu

A Clinical Investigation of the Discovery™ Elbow System

Zimmer Biomet logo

Zimmer Biomet

Status

Completed

Conditions

Humeral Fractures
Osteoarthritis
Avascular Necrosis
Rheumatoid Arthritis

Study type

Observational

Funder types

Industry

Identifiers

NCT00698867
ORTHO.CR.EX001

Details and patient eligibility

About

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of function will determine long-term clinical outcome while durability will be measured by the absence of revisions.

Full description

Patient follow-up outcomes measured by the ASES score, radiographs and adverse events/revisions.

Enrollment

118 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
  • Inflammatory arthritis
  • Revision where other devices or treatments have failed
  • Correction of functional deformity
  • Treatment of acute fractures or non-union about the elbow

Patient Selection factors to be considered include:

  • Need to obtain pain relief and improve function.
  • Ability and willingness to follow instructions including control of weight and activity levels.
  • Patients who are able and willing to return for follow-up evaluations.
  • Patients with a good nutritional state.
  • Patients with full skeletal maturity.
  • Patients of all races and gender.
  • Patients who are able to follow care instructions.

Exclusion criteria

  • Patients less than 18 years.
  • Patients with marked bone loss which would preclude proper fixation of the prosthesis.
  • Metabolic disorders, which may impair bone formation.
  • Patients who are pregnant.
  • Patients with an active or suspected infection in or around the elbow or distant foci of infections, which may spread to the implant site.
  • Patients with a highly communicable disease or diseases that may limit follow-up (e.g. immuno-compromised conditions, hepatitis, active tuberculosis, neoplastic disease, etc.).
  • Patients unwilling or unable to comply with a rehabilitation program for elbow replacement or who indicate difficulty or inability to return for follow-up visits prescribed by the study protocol.
  • Patients who qualify for inclusion in the study, but refuse consent to participate in the study.

Trial design

118 participants in 1 patient group

Discovery™ Elbow
Description:
Discovery™ Elbow minimally constrained

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems